Abstract
Background There is limited prospective evidence on the association between meat consumption and many common, non-cancerous health outcomes. We examined associations of meat intake with risk of 25 common conditions (other than cancer).
Methods We used data from 474 998 middle-aged men and women recruited into the UK Biobank study between 2006 and 2010 and followed-up until 2017 (mean follow-up of 8.0 years) with available information on meat intake at baseline (collected via touchscreen questionnaire), and linked hospital admissions and mortality data. For a large sub-sample, dietary intakes were re-measured using an online, 24-hour questionnaire.
Results In multi-variable adjusted (including body mass index (BMI)) Cox regression models corrected for multiple testing, a higher consumption of red and processed meat combined was associated with higher risks of ischaemic heart disease (HR per 70 g/day higher intake 1.14, 95% CI 1.06-1.22), pneumonia (1.28,1.15-1.41), diverticular disease (1.18,1.10-1.26), colon polyps (1.09,1.04-1.13), and diabetes (1.29,1.19-1.40), and a lower risk of iron deficiency anaemia (IDA), driven by a higher consumption of red meat (HR per 50g/day higher intake 0.77,0.69-0.86). Higher poultry meat intake was associated with higher risks of gastro-oesophageal reflux disease (HR per 30g/day higher intake 1.14, 1.06-1.23), gastritis and duodenitis (1.10,1.04-1.16), diverticular disease (1.09,1.04-1.16), and diabetes (1.13,1.06-1.20), and a lower risk of IDA (0.80,0.73-0.87).
Conclusions Higher red, processed, and poultry meat consumption was associated with higher risks of several common conditions; higher BMI accounted for a substantial proportion of these increased risks. Higher red and poultry meat consumption was associated with lower IDA risk.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
This work was supported by the Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP) [grant number 205212/Z/16/Z]; Cancer Research UK [grant number C8221/A29017] and the UK Medical Research Council [grant number MR/M012190/1].
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No additional data are available.
